CVE-2007-6763
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was...
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- Low
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
- Record
CVE-2007-6763- CVSS 3.0
- 8.8 High
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 6.5 Medium
AV:N/AC:L/Au:S/C:P/I:P/A:P - Weakness
- CWE-20
- Updated
- 2026-11-02
CVE List No score
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
- Record
CVE-2007-6763- Updated
- 2026-11-02
EUVDEUVD-2007-6719 No score
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
- Record
EUVD-2007-6719- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-9v4f-qv93-x5wc
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was...
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
- Record
GHSA-9v4f-qv93-x5wc- CVSS 3.0
- 8.8 High
CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-20
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| aliases, references, title | GitHub Advisories | |
| first indexed | CVE List, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2007-6763 is a high vulnerability (CVSS 8.8) in Sas Drug Development, published July 31, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.32%, the 70th percentile. No source names a fixed version.